Core Insights - 23andMe Research Institute has appointed two new members, Brad Margus and Stephen Quake, to its Board of Directors to enhance strategic guidance and operational impact for future generations [1][2]. Group 1: Board Members' Backgrounds - Brad Margus is the founder and chairman of the A-T Children's Project, which funds research on ataxia telangiectasia, a rare disease affecting two of his sons. He has extensive experience in biotechnology, having co-founded several companies and served on various boards [2]. - Stephen Quake, D.Phil., is a professor at Stanford University known for his pioneering work in single-molecule sequencing technology and immune repertoire analysis. He has received numerous accolades for his contributions to biotechnology [3]. Group 2: Organizational Goals - The 23andMe Research Institute aims to provide a robust experience for members to explore their DNA and maximize the impact of its dataset on understanding human genetics and health [2]. - The organization is committed to being a significant contributor to scientific advancement and improving health through crowdsourced research initiatives [5].